Pavlovian Conditioned Approach, Sign-tracking, average lever contact number on days 4 and 5 of testing
Tags: Behavior · Pavlovian conditioned approach · Conditioned reinforcement
Project: p50_paul_meyer_2014
2 loci · 7 genes with independent associations · 191 total associated genes
# | Chr | Start pos | End pos | # assoc genes | # joint models | Best TWAS P | Best GWAS P | Cond GWAS P | Joint genes |
---|---|---|---|---|---|---|---|---|---|
1 | chr1 | 149199615 | 150594931 | 5 | 1 | 4.01e-09 | 3.10e-09 | 1.16e-01 | Tenm4 |
2 | chr1 | 150731124 | 157827195 | 186 | 6 | 6.68e-10 | 1.94e-09 | 1.00e+00 | Dgat2 Gdpd4 LOC120099888 LOC120099889 Map6 Slco2b1 |
Tissue | RNA modality | # hits | % hits/tests | Avg chisq |
---|---|---|---|---|
Adipose | alternative polyA | 13 | 0.4 | 1.4 |
Adipose | alternative TSS | 15 | 0.4 | 1.45 |
Adipose | gene expression | 16 | 0.2 | 1.38 |
Adipose | isoform ratio | 15 | 0.3 | 1.43 |
Adipose | intron excision ratio | 4 | 0.1 | 1.28 |
Adipose | mRNA stability | 11 | 0.2 | 1.42 |
BLA | alternative polyA | 3 | 0.1 | 1.38 |
BLA | alternative TSS | 7 | 0.4 | 1.39 |
BLA | gene expression | 16 | 0.2 | 1.39 |
BLA | isoform ratio | 3 | 0.1 | 1.42 |
BLA | intron excision ratio | 3 | 0.1 | 1.35 |
BLA | mRNA stability | 5 | 0.2 | 1.37 |
Brain | alternative polyA | 2 | 0.1 | 1.36 |
Brain | alternative TSS | 11 | 0.3 | 1.33 |
Brain | gene expression | 15 | 0.1 | 1.35 |
Brain | isoform ratio | 7 | 0.1 | 1.36 |
Brain | intron excision ratio | 9 | 0.2 | 1.34 |
Brain | mRNA stability | 9 | 0.2 | 1.36 |
Eye | alternative polyA | 0 | 0 | 1.35 |
Eye | alternative TSS | 2 | 0.5 | 1.33 |
Eye | gene expression | 4 | 0.3 | 1.47 |
Eye | isoform ratio | 0 | 0 | 1.25 |
Eye | intron excision ratio | 1 | 0.1 | 1.42 |
Eye | mRNA stability | 0 | 0 | 1.56 |
IL | alternative polyA | 0 | 0 | 1.25 |
IL | alternative TSS | 0 | 0 | 1.18 |
IL | gene expression | 5 | 0.1 | 1.39 |
IL | isoform ratio | 1 | 0.1 | 1.37 |
IL | intron excision ratio | 1 | 0.1 | 1.32 |
IL | mRNA stability | 1 | 0.1 | 1.32 |
LHb | alternative polyA | 0 | 0 | 1.38 |
LHb | alternative TSS | 0 | 0 | 1.4 |
LHb | gene expression | 3 | 0.1 | 1.35 |
LHb | isoform ratio | 2 | 0.2 | 1.28 |
LHb | intron excision ratio | 0 | 0 | 1.3 |
LHb | mRNA stability | 0 | 0 | 1.24 |
Liver | alternative polyA | 1 | 0 | 1.27 |
Liver | alternative TSS | 4 | 0.1 | 1.37 |
Liver | gene expression | 18 | 0.2 | 1.41 |
Liver | isoform ratio | 7 | 0.2 | 1.37 |
Liver | intron excision ratio | 12 | 0.2 | 1.39 |
Liver | mRNA stability | 5 | 0.2 | 1.4 |
NAcc | alternative polyA | 2 | 0.1 | 1.41 |
NAcc | alternative TSS | 8 | 0.3 | 1.33 |
NAcc | gene expression | 13 | 0.2 | 1.38 |
NAcc | isoform ratio | 4 | 0.1 | 1.38 |
NAcc | intron excision ratio | 4 | 0.1 | 1.33 |
NAcc | mRNA stability | 8 | 0.2 | 1.37 |
OFC | alternative polyA | 4 | 0.4 | 1.4 |
OFC | alternative TSS | 0 | 0 | 1.22 |
OFC | gene expression | 3 | 0.1 | 1.36 |
OFC | isoform ratio | 3 | 0.2 | 1.44 |
OFC | intron excision ratio | 0 | 0 | 1.24 |
OFC | mRNA stability | 1 | 0.1 | 1.38 |
PL | alternative polyA | 11 | 0.3 | 1.52 |
PL | alternative TSS | 3 | 0.1 | 1.36 |
PL | gene expression | 16 | 0.2 | 1.38 |
PL | isoform ratio | 4 | 0.1 | 1.35 |
PL | intron excision ratio | 5 | 0.1 | 1.33 |
PL | mRNA stability | 7 | 0.2 | 1.37 |
pVTA | alternative polyA | 2 | 0.1 | 1.45 |
pVTA | alternative TSS | 3 | 0.2 | 1.34 |
pVTA | gene expression | 10 | 0.2 | 1.39 |
pVTA | isoform ratio | 4 | 0.2 | 1.33 |
pVTA | intron excision ratio | 4 | 0.1 | 1.32 |
pVTA | mRNA stability | 3 | 0.2 | 1.35 |
RMTg | alternative polyA | 0 | 0 | 1.18 |
RMTg | alternative TSS | 1 | 0.2 | 1.28 |
RMTg | gene expression | 0 | 0 | 1.4 |
RMTg | isoform ratio | 0 | 0 | 1.15 |
RMTg | intron excision ratio | 0 | 0 | 1.38 |
RMTg | mRNA stability | 0 | 0 | 1.36 |